ArticleCancer research2019

Aberrant Activation of β-Catenin Signaling Drives Glioma Tumorigenesis via USP1-Mediated Stabilization of EZH2.

Li Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.